Researchers sought to determine the effect of changes in screening guidelines on incidence of breast cancer by stage at diagnosis and surgical management.
The 5-year recurrence-free survival rate was 75% in the younger age group and 73% in the older age group. Age may not be a prognostic factor for patients with cervical cancer, according to researchers ...
In the primary efficacy population, the median progression-free survival was not reached in the nivolumab-ipilimumab arm and was 5.9 months in the chemotherapy arm. The combination of nivolumab and ...
At a median follow-up of 12.3 months, 44% of patients with PTCL had an objective response by blinded independent central review in this study, with a median response duration of 11.9 months. Among ...
Researchers developed an assay kit for TAT, then conducted a retrospective analysis to determine its ability to predict VTE in patients with cervical cancer.
The results of this first phase 2 study of belzutifan combined with cabozantinib suggest that dual targeting of HIF-2α and VEGF pathways might be an effective first-line treatment strategy in advanced ...
Researchers conducted a randomized controlled trial to assess the need for postoperative radioiodine therapy among patients with low-risk thyroid cancer.
Researchers found that receipt of neoadjuvant and adjuvant chemotherapy were associated with inadequate ovarian function suppression. Researchers say they have identified several factors that may be ...